株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血液透析装置:パイプライン分析

Hemodialysis Equipment - Medical Devices Pipeline Assessment, 2016

発行 GlobalData 商品コード 336434
出版日 ページ情報 英文 118 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
血液透析装置:パイプライン分析 Hemodialysis Equipment - Medical Devices Pipeline Assessment, 2016
出版日: 2016年11月01日 ページ情報: 英文 118 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中の血液透析装置のパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・地域別・分野別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の製品開発・資本取引の動きなどを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

  • 血液透析装置の概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:認証時期別 (推定)
  • 現在進行中の治験

第4章 血液透析装置:開発中のパイプライン製品 (企業別)

  • 血液透析装置の開発企業:パイプライン製品 (開発段階別)
  • 血液透析装置:開発段階別のパイプライン製品の一覧

第5章 血液透析装置の開発企業・製品の概要

  • Bioconnect Systems, Inc.
    • パイプライン製品および進行中の治験の概要
  • Blood Purification Technologies, Inc.
  • Clil Medical
  • ExThera Medical LLC.
  • Hemova Medical
  • Katharos, Inc.
  • Medtronic plc
  • Outset Medical, Inc.
  • Phraxis, Inc.

第6章 血液透析装置:昨今の市場動向

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0239EPD

GlobalData's Medical Devices sector report, "Hemodialysis Equipment - Medical Devices Pipeline Assessment, 2016" provides an overview of Hemodialysis Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemodialysis Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hemodialysis Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hemodialysis Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hemodialysis Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Hemodialysis Equipment Overview

3. Products under Development

  • 3.1. Hemodialysis Equipment - Pipeline Products by Stage of Development
  • 3.2. Hemodialysis Equipment - Pipeline Products by Segment
  • 3.3. Hemodialysis Equipment - Pipeline Products by Territory
  • 3.4. Hemodialysis Equipment - Pipeline Products by Regulatory Path
  • 3.5. Hemodialysis Equipment - Pipeline Products by Estimated Approval Date
  • 3.6. Hemodialysis Equipment - Ongoing Clinical Trials

4. Hemodialysis Equipment - Pipeline Products under Development by Companies

  • 4.1. Hemodialysis Equipment Companies - Pipeline Products by Stage of Development
  • 4.2. Hemodialysis Equipment - Pipeline Products by Stage of Development

5. Hemodialysis Equipment Companies and Product Overview

  • 5.1. AngioDynamics, Inc. Company Overview
    • 5.1.1. AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Baxter International Inc. Company Overview
    • 5.2.1. Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Bioconnect Systems, Inc. Company Overview
    • 5.3.1. Bioconnect Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Clil Medical Company Overview
    • 5.4.1. Clil Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Columbia University Company Overview
    • 5.5.1. Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Eqalix, Inc. Company Overview
    • 5.6.1. Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. ExThera Medical Corporation Company Overview
    • 5.7.1. ExThera Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Fresenius Medical Care AG & Co. KGaA Company Overview
    • 5.8.1. Fresenius Medical Care AG & Co. KGaA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Hemova Medical Company Overview
    • 5.9.1. Hemova Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Katharos, Inc. Company Overview
    • 5.10.1. Katharos, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Medtronic plc Company Overview
    • 5.11.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Nephros Inc Company Overview
    • 5.12.1. Nephros Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Occlutech International AB Company Overview
    • 5.13.1. Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Outset Medical, Inc. Company Overview
    • 5.14.1. Outset Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Oxford Biomaterials Ltd Company Overview
    • 5.15.1. Oxford Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Phraxis, Inc. Company Overview
    • 5.16.1. Phraxis, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Stent Tek Ltd Company Overview
    • 5.17.1. Stent Tek Ltd Pipeline Products & Ongoing Clinical Trials Overview

6. Hemodialysis Equipment- Recent Developments

  • 6.1. Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results
  • 6.2. Sep 29, 2016: Cantel Medical Reports Record Results for the Fourth Quarter Ended July 31, 2016
  • 6.3. Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
  • 6.4. Sep 14, 2016: DaVita Names New President for Florida Medical Group Operations
  • 6.5. Sep 01, 2016: Cantel Medical Promotes Seth M. Yellin to Executive Vice President
  • 6.6. Aug 30, 2016: The Everett Clinic Announces Leadership Transitions
  • 6.7. Aug 30, 2016: DaVita Kidney Care Welcomes Dr. Bryan Becker to Physician Leadership Team
  • 6.8. Aug 25, 2016: Medtronic Reports First Quarter Financial Results
  • 6.9. Aug 23, 2016: DaVita Kidney Care Welcomes Dr. Jeff Giullian to Physician Leadership Team
  • 6.10. Aug 17, 2016: DaVita Hospital Services Receives Re-Accreditation from The Joint Commission
  • 6.11. Aug 17, 2016: Fresenius Kabi investing nearly $250 million to expand plant near Chicago
  • 6.12. Aug 11, 2016: Aethlon Medical Announces Fiscal 2017 First Quarter Results
  • 6.13. Aug 08, 2016: DaVita HealthCare Partners 2nd Quarter 2016 Results
  • 6.14. Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results
  • 6.15. Aug 04, 2016: NxStage Reports Second Quarter Financial Results And Raises Full-Year Revenue Guidance
  • 6.16. Aug 01, 2016: AngioDynamics to Raise Funds through Public Offering of Shares
  • 6.17. Aug 01, 2016: Fresenius Medical Care posts accelerated earnings growth in the 2nd quarter
  • 6.18. Aug 01, 2016: Cantel Medical Names Jorgen B. Hansen as New President and CEO
  • 6.19. Jul 28, 2016: Mesa Labs Reports 16 Percent Increase in First Quarter Revenues
  • 6.20. Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016
  • 6.21. Jul 27, 2016: Baxter Presents New Evidence Demonstrating REVACLEAR Dialyzer Associated with Lower Drug Use During Hemodialysis
  • 6.22. Jul 26, 2016: Merit Medical Announces Appointment of New Director
  • 6.23. Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results
  • 6.24. Jul 26, 2016: Bard Announces Second Quarter Results
  • 6.25. Jul 26, 2016: Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016
  • 6.26. Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer
  • 6.27. Jul 18, 2016: DaVita Joins Patients and Providers to Urge Congress to Pass Bipartisan Dialysis PATIENT Demonstration Act
  • 6.28. Jul 13, 2016: DaVita Appoints Phyllis R. Yale to Board of Directors
  • 6.29. Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results
  • 6.30. Jul 01, 2016: DaVita HealthCare Partners Names Oraida Roman President of Colorado Springs Health Partners
  • 6.31. Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
  • 6.32. Jun 29, 2016: Aethlon Medical Announces Fiscal 2016 Results
  • 6.33. Jun 28, 2016: Aethlon Medical Files Registration Statement for Public Offering of Shares for up to USD12.5 Million
  • 6.34. Jun 26, 2016: Fresenius appoints Stephan Sturm as new Chief Executive Officer - Ulf Mark Schneider leaves the company to pursue another opportunity
  • 6.35. Jun 22, 2016: Aethlon Medical Set To Join Russell Microcap Index
  • 6.36. Jun 17, 2016: Cantel Medical Announces Appointment of Dr. Ronnie Myers to its Board of Directors
  • 6.37. Jun 13, 2016: Amar Desai, M.D., Returns to DaVita HealthCare Partners
  • 6.38. Jun 08, 2016: Cantel Medical Announces Record Financial Results for Third Quarter 2016
  • 6.39. Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day
  • 6.40. Jun 02, 2016: Mesa Labs Reports Record Net Income and Revenues for year ending March 31, 2016
  • 6.41. May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results
  • 6.42. May 24, 2016: Baxter Unveils Innovative THERANOVA Dialyser at 2016 ERA-EDTA Congress
  • 6.43. May 23, 2016: Baxter Presents Data Focused on Elevating the Quality of Care for Renal Patients
  • 6.44. May 12, 2016: Fresenius Medical Care expects continued, strong growth - Annual General Meeting approves 19th consecutive dividend increase
  • 6.45. May 10, 2016: ICU Medical Announces First Quarter 2016 Results
  • 6.46. May 10, 2016: DaVita Appoints President for Kidney Care Business in Asia Pacific
  • 6.47. May 09, 2016: Baxter Highlights Business Strategies and Innovation at 2016 Investor Conference
  • 6.48. May 04, 2016: Dialog+ Hemodialysis Systems by B. Braun Medical: Class I Recall - Defective Conductivity Sensors
  • 6.49. May 04, 2016: NxStage Reports First Quarter Financial Results
  • 6.50. May 03, 2016: Strong start into the year - Double-digit earnings growth in constant currency - Fresenius confirms Group guidance for 2016
  • 6.51. May 03, 2016: Fresenius Medical Care reports strong start to the year 2016
  • 6.52. May 02, 2016: Fresenius Renal Therapies Announces the Introduction of Next Generation Sentinel Technology to Support Fluid Management Challenges in the End Stage Renal Disease Community
  • 6.53. Apr 25, 2016: Fresenius Medical Care North America to Present Range of Clinical Findings Focused on Improving Renal Patient Care and Health Outcomes at the National Kidney Foundation 2016. Spring Clinical Meetings
  • 6.54. Apr 21, 2016: Nephros Announces Submission Of Special 510(K) Application To The FDA For The Endopurtm Ultrafilter
  • 6.55. Apr 13, 2016: Fresenius Medical Care North America's Dialysis Division Is Now Fresenius Kidney Care
  • 6.56. Apr 08, 2016: Fresenius Vamed lays foundation stone for new university hospital building
  • 6.57. Apr 07, 2016: AngioDynamics Reports Fiscal 2016 Third Quarter Results
  • 6.58. Mar 24, 2016: Millin Enterprises Raises Funds through Series A financing
  • 6.59. Mar 23, 2016: B. Braun's growth trend continues
  • 6.60. Mar 18, 2016: CryoLife Sells Distribution Rights of ProCol Vascular Bioprosthesis to LeMaitre Vascular for USD2 Million
  • 6.61. Mar 18, 2016: LeMaitre Vascular Acquires ProCol Vascular Bioprosthesis Product Line from Hancock Jaffe Labs for USD0.6 Million
  • 6.62. Mar 16, 2016: Nephros Launches SSUmini
  • 6.63. Mar 16, 2016: Nephros Provides S100 Update
  • 6.64. Mar 15, 2016: Peripal Raises Funds in First Tranche of Series A Venture Financing
  • 6.65. Mar 11, 2016: Fresenius Medical Care announces proposals for election to the Supervisory Board by the Annual General Meeting on May 12, 2016
  • 6.66. Mar 10, 2016: Cantel Medical Reports Record Results for the Second Quarter Ended January 31, 2016
  • 6.67. Feb 24, 2016: Fresenius Medical Care reports fourth quarter and full year 2015 results
  • 6.68. Feb 24, 2016: Outstanding 2015 financial results - 25% dividend increase proposed - Positive outlook for 2016 - New mid-term growth targets
  • 6.69. Feb 24, 2016: NxStage Presents New Findings on Lowering HHD Attrition Through Nx2me Connected Health Technology and Increased Training Volume
  • 6.70. Feb 22, 2016: Funding For Lawsuits Extends GranuFlo Lawsuit Funding
  • 6.71. Feb 17, 2016: Fresenius Medical Care reaches agreement in principle to resolve the GranuFlo/NaturaLyte product liability litigation
  • 6.72. Feb 04, 2016: Aethlon Medical Announces Fiscal 2016 Third Quarter Results
  • 6.73. Feb 03, 2016: ICU Medical Announces Fourth Quarter and Fiscal Year 2015 Results
  • 6.74. Feb 02, 2016: Mesa Labs Reports Record Third Quarter Revenues and Adjusted Net Income
  • 6.75. Jan 28, 2016: Fresenius Medical Care announces change in Management Board
  • 6.76. Jan 18, 2016: Nephros Announces Publication of Observational Trial of DSU-D in a Hospital-Based Dialysis Facility
  • 6.77. Jan 05, 2016: Argon Medical Devices Acquires Three Vascular Products from Rex Medical
  • 6.78. Dec 31, 2015: Peripal Raises Funds in Seed Financing
  • 6.79. Dec 10, 2015: Cantel Medical Reports Record Results For The First Quarter Ended October 31, 2015
  • 6.80. Dec 07, 2015: ExThera Medical Announces Initiation of Clinical Trials of its Seraph Microbind Affinity Blood Filter
  • 6.81. Dec 04, 2015: Change in B. Braun Management Board
  • 6.82. Nov 17, 2015: Fresenius Medical Care Opens Research and Development Center in Shanghai, China
  • 6.83. Nov 16, 2015: Aethlon Medical Announces Fiscal 2016 Second Quarter Results
  • 6.84. Nov 05, 2015: Fresenius Medical Care's Knoxville Manufacturing Plant on Schedule to Help Ease Nationwide Shortage of Peritoneal Dialysis Solution
  • 6.85. Nov 05, 2015: ICU Medical Announces Third Quarter 2015 Results
  • 6.86. Nov 03, 2015: NxStage Reports Record Third Quarter Financial Results And Increases Financial Guidance For 2015
  • 6.87. Nov 02, 2015: Mesa Labs Reports Record Second Quarter Revenues
  • 6.88. Oct 27, 2015: Nephros Announces FDA 510 Submission of S100 Ultrafilter

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Hemodialysis Equipment - Pipeline Products by Stage of Development
  • Table 2: Hemodialysis Equipment - Pipeline Products by Segment
  • Table 3: Hemodialysis Equipment - Pipeline Products by Territory
  • Table 4: Hemodialysis Equipment - Pipeline Products by Regulatory Path
  • Table 5: Hemodialysis Equipment - Pipeline Products by Estimated Approval Date
  • Table 6: Hemodialysis Equipment - Ongoing Clinical Trials
  • Table 7: Hemodialysis Equipment Companies - Pipeline Products by Stage of Development
  • Table 8: Hemodialysis Equipment - Pipeline Products by Stage of Development
  • Table 9: AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Next Generation Dialysis Device - Product Status
  • Table 11: Next Generation Dialysis Device - Product Description
  • Table 12: Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Next Gen ICHD Monitor - Product Status
  • Table 14: Next Gen ICHD Monitor - Product Description
  • Table 15: THERANOVA Dialyser - Product Status
  • Table 16: THERANOVA Dialyser - Product Description
  • Table 17: Bioconnect Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Optiflow Vascular Anastomotic System - Product Status
  • Table 19: Optiflow Vascular Anastomotic System - Product Description
  • Table 20: Clil Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Implantable Artificial Kidney - Product Status
  • Table 22: Implantable Artificial Kidney - Product Description
  • Table 23: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Hemodialysis Access Flow Restrictor Device - Product Status
  • Table 25: Hemodialysis Access Flow Restrictor Device - Product Description
  • Table 26: Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: RenalEase - Product Status
  • Table 28: RenalEase - Product Description
  • Table 29: ExThera Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Seraph 100 - Product Status
  • Table 31: Seraph 100 - Product Description
  • Table 32: Fresenius Medical Care AG & Co. KGaA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Peritoneal Dialysis Cycler - Product Status
  • Table 34: Peritoneal Dialysis Cycler - Product Description
  • Table 35: Hemova Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Hemova Port Device - Product Status
  • Table 37: Hemova Port Device - Product Description
  • Table 38: Katharos, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Phosfilter - Product Status
  • Table 40: Phosfilter - Product Description
  • Table 41: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Dialysis Device - Product Status
  • Table 43: Dialysis Device - Product Description
  • Table 44: Nephros Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: EndoPur 10 Endotoxin Filter Cartridge - Product Status
  • Table 46: EndoPur 10 Endotoxin Filter Cartridge - Product Description
  • Table 47: EndoPur 20 Endotoxin Filter Cartridge - Product Status
  • Table 48: EndoPur 20 Endotoxin Filter Cartridge - Product Description
  • Table 49: EndoPur 30 Endotoxin Filter Cartridge - Product Status
  • Table 50: EndoPur 30 Endotoxin Filter Cartridge - Product Description
  • Table 51: EndoPur 40 Endotoxin Filter Cartridge - Product Status
  • Table 52: EndoPur 40 Endotoxin Filter Cartridge - Product Description
  • Table 53: Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Dialysis Prosthesis Device - Product Status
  • Table 55: Dialysis Prosthesis Device - Product Description
  • Table 56: Outset Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Tablo System - Home Use - Product Status
  • Table 58: Tablo System - Home Use - Product Description
  • Table 59: Outset Medical, Inc. - Ongoing Clinical Trials Overview
  • Table 60: Tablo System - Home Use - A Prospective Multicenter, Open Label, Non-randomized, Cross-over Study Evaluating the Use of the Tablo Hemodialysis System In-center and In-home by Subjects with End Stage Renal Disease (ESRD) who are on Stable Dialysis Regimens
  • Table 61: Oxford Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: SpiderGraft - Product Status
  • Table 63: SpiderGraft - Product Description
  • Table 64: Phraxis, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Phraxis InterGraft - Product Status
  • Table 66: Phraxis InterGraft - Product Description
  • Table 67: Stent Tek Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: ePATH System - Product Status
  • Table 69: ePATH System - Product Description
  • Table 70: Glossary

List of Figures

  • Figure 1: Hemodialysis Equipment - Pipeline Products by Stage of Development
  • Figure 2: Hemodialysis Equipment - Pipeline Products by Segment
  • Figure 3: Hemodialysis Equipment - Pipeline Products by Territory
  • Figure 4: Hemodialysis Equipment - Pipeline Products by Regulatory Path
  • Figure 5: Hemodialysis Equipment - Pipeline Products by Estimated Approval Date
  • Figure 6: Hemodialysis Equipment - Ongoing Clinical Trials
Back to Top